US Securities and Exchange Commission (SEC)

Developer of Revolutionary “Powder” Epinephrine Auto-Injector Raises $12 Million

Dave Bloom - 2019/01/21

Windgap Medical is securing funding to continue development.

Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate

Dave Bloom - 2019/01/16

The FDA has shelved consideration of the drug until funding is restored.

Department of Justice Investigating Mylan Regarding Trade Compliance for Certain Products

Dave Bloom - 2018/05/15

Manufacturer of EpiPen complies with DOJ requests and warrant issued by a special prosecutor's office in Milan, Italy.

Food Allergen Detector Draws $20 Million in Venture Funding

Dave Bloom - 2017/10/25

The device joins others intended for use as portable "point of consumption" testers.

Connect with Us

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 15 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: US Securities and Exchange Commission (SEC)

Developer of Revolutionary “Powder” Epinephrine Auto-Injector Raises $12 Million

Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate

Department of Justice Investigating Mylan Regarding Trade Compliance for Certain Products

Food Allergen Detector Draws $20 Million in Venture Funding

Connect with Us